💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Gilead Sciences, Inc. (GILD)
« Back to company indexGILD Chatter Timeline
Stock Ticker for GILD
Most Active Tweeters for GILD
| User | Tweets |
|---|---|
| @bs_marker | 15 |
| @TradeWithAlerts | 12 |
| @MarcJacksonLA | 8 |
| @quantisnow | 8 |
| @dailycandlestix | 7 |
Recent Tweets for GILD
 |
@ShogunTrade $GILD UltraAlgo Alert | Awaiting Buy Signal on Stock GILD https://t.co/Gz6PjN91jY 1:09am |
 |
@topiy17948 $GILD Real price will come out soon; Follow price targets ~~ https://t.co/5QBk9gU5kD September 16th 2021, 9:09pm |
 |
@ASeizew @AAABiotech Actually think the opposite may have happened. $GILD might have approached Allen about buying $GRTS, Al… https://t.co/wV0Tz2GURq September 16th 2021, 8:09pm |
 |
@AAABiotech @ASeizew $GILD I guess Allen is selling the company and $GRTS and gilead wants to be involved and have a piece of a… https://t.co/CKZyfHSRDC September 16th 2021, 8:09pm |
 |
@YuZhu4 RT @Maximus_Holla: $GRTS so reading into the offering, very impressed! private placement from Red mile, $GILD and Frazier lol! which idi… September 16th 2021, 8:09pm |
 |
@Maximus_Holla $GRTS so reading into the offering, very impressed! private placement from Red mile, $GILD and Frazier lol! whic… https://t.co/OpW6VObznR September 16th 2021, 8:09pm |
 |
@dailycandlestix $GILD Below Avg Volume Daily appearances since 2010: 419 Close 5 days later ±: Avg: -0.17 SD: 2.34 Worst: -14.50 Be… https://t.co/hk3o7rzLjV September 16th 2021, 8:09pm |
|
@dailycandlestix $GILD Dark Cloud Cover Daily appearances since 2010: 101 Close 5 days later ±: Avg: -0.01 SD: 2.10 Worst: -8.44 Bes… https://t.co/kZb9w1uXZB September 16th 2021, 8:09pm |
|
@ASeizew @AAABiotech Its also a bone to $GILD since they paid nearly double this price to buy one million shares when they m… https://t.co/bFSLvoWZkr September 16th 2021, 8:09pm |
 |
@vimarblanco $GILD Awaiting Short signal on GILD https://t.co/UarDvkfArX September 16th 2021, 8:09pm |
 |
@Benzinga RT @MarcJacksonLA: $GILD Gilead Churns Out Additional Trodelvy Data $GILD https://t.co/Vay3zB3Dgk # via @benzinga September 16th 2021, 7:09pm |
 |
@the_day_tradar $GILD Real price will come out soon: Follow price targets.. https://t.co/MChi7vTTtH September 16th 2021, 6:09pm |
 |
@ReplyGuy_Pete @SkeleCap @ParmenidesvonE $GILD has perplexed me for YEARS. I understand that this shit is not easy and am armchai… https://t.co/hRyfnkfXTh September 16th 2021, 6:09pm |
 |
@newsfilterio Gilead Churns Out Additional Trodelvy Data $GILD https://t.co/ifVi7DXb2B September 16th 2021, 5:09pm |
 |
@MarcJacksonLA $GILD Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L Metastatic Triple-Negative Brea… https://t.co/TGcqVVeHOS September 16th 2021, 5:09pm |
|
@MarcJacksonLA $GILD Gilead Churns Out Additional Trodelvy Data $GILD https://t.co/Vay3zB3Dgk # via @benzinga September 16th 2021, 5:09pm |
 |
@EdgeTrader Day trader alert! #HEALTHCARE sector The most overvalued symbol is $GILD. The most undervalued is $LLY. Free pdf… https://t.co/wLxmjqx5eB September 16th 2021, 5:09pm |
 |
@StckPro $GILD NEW ARTICLE : Gilead Churns Out Additional Trodelvy Data https://t.co/aOrjRo2ULr Get all the latest $GILD rel… https://t.co/5K7JeTQOuQ September 16th 2021, 5:09pm |
 |
@bs_marker Stock: $GILD - Gilead Sciences *** NEWS *** Gilead Sciences (GILD) Trading Report - Stock Traders Daily… https://t.co/OCfhvQxGkg September 16th 2021, 5:09pm |
 |
@IOInvestors Gilead $GILD Announces New Data Shows Trodelvy Increases Survival Benefit in Metastatic Triple-Negative Breast Canc… https://t.co/koGXCVyQHn September 16th 2021, 4:09pm |
 |
@nehato2408 $GILD Real price will come out soon; Follow price targets ~~ https://t.co/Q0Xkpyv5WE September 16th 2021, 3:09pm |
 |
@SismasStock $GILD waiting for Buy signal on GILD https://t.co/6BvG5V6ebw September 16th 2021, 3:09pm |
 |
@marketcycles $GILD | Gilead Sciences ($GILD) Trading Report (GILD) https://t.co/K93m6Z84Gi https://t.co/82JviUxwLk September 16th 2021, 3:09pm |
 |
@Tickeron $GILD's Aroon indicator reaches into Uptrend on August 27, 2021. View odds for this and other indicators:… https://t.co/rZNC9Xo8MC September 16th 2021, 1:09pm |
 |
@Briefingcom $GILD: Gilead Sciences reports Trodelvy significantly improved quality of life over standard of care in 2L+... https://t.co/A3TwdIwq6b September 16th 2021, 1:09pm |
|
@Briefingcom $GILD: Gilead Sciences announces new data from the Phase 3 ASCENT study evaluating Trodelvy in patients with... https://t.co/VgFPCEfMEh September 16th 2021, 1:09pm |
 |
@LogycThaLion $GILD Gilead Sciences announces new data from the Phase 3 ASCENT study evaluating Trodelvy in patients with relapse… https://t.co/wYmDCuKnk4 September 16th 2021, 12:09pm |
|
@LogycThaLion $GILD Gilead Sciences reports Trodelvy significantly improved quality of life over standard of care in 2L+ metastat… https://t.co/Tio9mRKMHB September 16th 2021, 12:09pm |
 |
@OpenOutcrier $GILD (+0.1% pre) Gilead (GILD) Announces New Data Demonstrate Trodelvy Survival Benefit in Metastatic Triple-Negat… https://t.co/xPxi05jrDY September 16th 2021, 12:09pm |
 |
@TSOH_Investing RT @SkeleCap: This is a multibillion dollar bill literally lying on the sidewalk and $GILD refuses to pick it up. Why? Inertia and inertia.… September 16th 2021, 12:09pm |
 |
@otcdynamics $GILD New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Negative Breast Cancer Patients Regardle… https://t.co/T06TBRjMUs September 16th 2021, 11:09am |
|
@otcdynamics $GILD Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple-Negative Brea… https://t.co/JyswYilWjN September 16th 2021, 11:09am |
 |
@63_hyacinth Gilead announces new ASCENT study data $GILD September 16th 2021, 11:09am |
|
@63_hyacinth Gilead says data evaluating Trodelvy in patients with TNBC show improvement $GILD September 16th 2021, 11:09am |
|
@StckPro $GILD NEW ARTICLE : Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple… https://t.co/MO9OUY0V2n September 16th 2021, 11:09am |
|
@StckPro $GILD NEW ARTICLE : New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Negative Breast Cancer Pat… https://t.co/iY7sYgpenl September 16th 2021, 11:09am |
 |
@FlashAlert_me $GILD [15s. delayed]: Issued Press Release on September 16, 07:00:00: Trodelvy® Significantly Improved Quality of L… https://t.co/p9CcGTCR9B September 16th 2021, 11:09am |
|
@FlashAlert_me $GILD [15s. delayed]: Issued Press Release on September 16, 07:00:00: New Data Demonstrate Trodelvy® Survival Benef… https://t.co/nXbYnXNbkQ September 16th 2021, 11:09am |
 |
@StockNewsBot2 $GILD Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple-Negative Brea… https://t.co/92fyn8MdAr September 16th 2021, 11:09am |
|
@StockNewsBot2 $GILD New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Negative Breast Cancer Patients Regardle… https://t.co/neoYJCDRN1 September 16th 2021, 11:09am |
 |
@quantisnow $GILD ? New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Negative Breast Cancer Patients Regard… https://t.co/IpfpVtALvP September 16th 2021, 11:09am |
|
@quantisnow $GILD ? Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple-Negative Br… https://t.co/HJyn1ecAAp September 16th 2021, 11:09am |
 |
@stock_titan $GILD Trodelvy® Significantly Improved Quality of Life Over Standard of Care in 2L+ Metastatic Triple-Negative Brea… https://t.co/XHKlfbSdIz September 16th 2021, 11:09am |
|
@stock_titan $GILD New Data Demonstrate Trodelvy® Survival Benefit in Metastatic Triple-Negative Breast Cancer Patients Regardle… https://t.co/bvp2b3YY1X September 16th 2021, 11:09am |
|
@bs_marker Stock: $GILD - Gilead Sciences *** NEWS *** Fate Therapeutics: We Will Wait For Durability Data - Seeking Alpha… https://t.co/1oFrBjH44q September 16th 2021, 1:09am |
 |
@axelroark $GILD Why not https://t.co/X3OpvgU44q September 16th 2021, 12:09am |
|
@StckPro $GILD NEW ARTICLE : Gilead Sciences Might Return To The Glory Days Of Past https://t.co/bg1lGNVBPh Get all the late… https://t.co/xaOAYmEWWu September 15th 2021, 11:09pm |
 |
@SeekingAlpha $GILD - Gilead Sciences Might Return To The Glory Days Of Past. https://t.co/reUbaQDjmB #investing #economy #business September 15th 2021, 11:09pm |
|
@MarcJacksonLA $GILD Pharma giant Gilead Sciences considered Durham before selecting Raleigh for 275 jobs https://t.co/7lfCKRselM via @TriangleBIZJrnl September 15th 2021, 8:09pm |
|
@StckPro $GILD NEW ARTICLE : Gilead Sciences, Inc. (GILD) CEO Dan O'Day Presents at Morgan Stanley 19th Annual Global Health… https://t.co/85GXX6ArHy September 15th 2021, 8:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?